SEAGEN INC's ticker is SGEN and the CUSIP is 81181C104. A total of 541 filers reported holding SEAGEN INC in Q2 2022. The put-call ratio across all filers is 0.37 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $277,003,194 | -14.9% | 1,305,695 | -22.8% | 0.06% | -12.1% |
| Q2 2023 | $325,353,630 | +87.8% | 1,690,500 | +97.6% | 0.07% | +78.4% |
| Q1 2023 | $173,228,878 | +315.3% | 855,578 | +163.6% | 0.04% | +270.0% |
| Q4 2022 | $41,707,921 | -69.4% | 324,550 | -67.4% | 0.01% | -71.4% |
| Q3 2022 | $136,205,000 | +117.0% | 995,438 | +180.6% | 0.04% | +133.3% |
| Q2 2022 | $62,771,000 | +62.8% | 354,765 | +32.6% | 0.02% | +150.0% |
| Q1 2022 | $38,551,000 | -70.9% | 267,619 | -68.8% | 0.01% | +50.0% |
| Q4 2021 | $132,426,000 | +86.2% | 856,580 | +104.5% | 0.00% | -55.6% |
| Q3 2021 | $71,122,000 | +44.6% | 418,857 | +34.5% | 0.01% | +28.6% |
| Q2 2021 | $49,171,000 | -12.4% | 311,442 | -23.0% | 0.01% | -22.2% |
| Q1 2021 | $56,138,000 | -65.0% | 404,275 | -55.8% | 0.01% | -35.7% |
| Q4 2020 | $160,316,000 | – | 915,368 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baker Brothers Advisors | 46,912,266 | $8,300,656,000 | 47.09% |
| Eagle Health Investments LP | 262,502 | $46,447,000 | 10.83% |
| EcoR1 Capital, LLC | 1,008,628 | $178,467,000 | 6.16% |
| Lagoda Investment Management, L.P. | 49,460 | $8,751,000 | 5.80% |
| Redmile Group, LLC | 854,013 | $151,109,000 | 5.77% |
| Nan Fung Group Holdings Ltd | 47,096 | $8,333,000 | 5.72% |
| Atika Capital Management LLC | 282,500 | $49,985,000 | 5.62% |
| Avoro Capital Advisors LLC | 1,525,000 | $269,834,000 | 5.33% |
| Parkman Healthcare Partners LLC | 76,626 | $13,558,000 | 4.99% |
| Artal Group S.A. | 525,000 | $92,894,000 | 4.96% |